Fu Q, et al
A First-Mover Advantage in Generic Semaglutide Dr Reddys has achieved a critical milestone: First Indian company to receive DCGI approval for generic semaglutide Immediate market entry post-patent expiry Positioned as an early challenger to innovator brands This gives the company a strong edge in what is quickly becoming one of the most competitive therapy segments
It should be noted that the cerebral cortex and the cerebellum interestingly lack the expression of the GLP-1R in rat models [51]
Chen, H., Zhang, X., Liao, N., Ji, Y., Mi, L., Gan, Y., Su, Y., & Wen, F
Most GLP-1 medications (including semaglutide, dulaglutide, and liraglutide) do not need to be timed with meals, though some exceptions exist (such as immediate-release exenatide)
However, chronic low-grade inflammation has been associated with several metabolic and health concerns